Vista Pharma.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE427C01021
NSEID:
BSEID: 524711

INR

12.07

0.57 (4.96%)

BSENSE

Apr 11, 12:05 PM

BSE+NSE Vol: 1.63 k

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Divi's Lab.

Cipla

Sun Pharma.Inds.

Torrent Pharma

Roopa Industries

Mankind Pharma

Deccan Healthcar

Vista Pharma.

Chandra Bhagat

Shelter Pharma

Mono Pharmacare

Why is Vista Pharmaceuticals Ltd ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of -21.80% and Operating profit at -191.80% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.51

Flat results in Dec 24

NO KEY NEGATIVE TRIGGERS

Stock is technically in a Mildly Bearish range

The stocks MACD and KST technical factors are also Bearish

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -12.54%, its profits have risen by 63.2%

Underperformed the market in the last 1 year

Even though the market (BSE 500) generated negative returns of -1.04% in the last 1 year, its fall in the stock was much higher with a return of -12.54%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Vista Pharma. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Vista Pharma.

-12.54%

-0.26

47.94%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-21.80%

EBIT Growth (5y)

-191.80%

EBIT to Interest (avg)

-3.51

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.36

Tax Ratio

29.17%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

-5.03%

ROE (avg)

0.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.25

EV to EBIT

-14.67

EV to EBITDA

-18.43

EV to Capital Employed

1.21

EV to Sales

5.26

PEG Ratio

Dividend Yield

ROCE (Latest)

-15.40%

ROE (Latest)

-8.58%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...